MRLN (MRLN) Set to Report Q2 Earnings on August 15, 2026
MRLN (NASDAQ:MRLN) is scheduled to report its Q2 earnings results on August 15, 2026 after market close.
Read moreReal-time context
Company earnings results and notable reporting developments.
MRLN (NASDAQ:MRLN) is scheduled to report its Q2 earnings results on August 15, 2026 after market close.
Read moreSharonAI Holdings Inc. (NASDAQ:SHAZ) is scheduled to report its Q2 earnings results on August 15, 2026 after market close.
Read moreLCLN (NASDAQ:LCLN) is scheduled to report its Q2 earnings results on August 15, 2026 after market close.
Read moreFAC (NASDAQ:FAC) is scheduled to report its Q2 earnings results on August 15, 2026 after market close.
Read moreMetalla Royalty (AMEX:MTA) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreFirm Cap Mortgage Inv (NYSE:FC) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreCanlan Ice Sports (NYSE:ICE) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreSatellos Bioscience (NASDAQ:MSLE) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreAtrium Therapeutics (NASDAQ:RNA) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreTempest Therapeutics (NASDAQ:TPST) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreInstil Bio (NASDAQ:TIL) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreEnsysce Biosciences (NASDAQ:ENSC) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreEdesa Biotech (NASDAQ:EDSA) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreCadrenal Therapeutics (NASDAQ:CVKD) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreCheetah Net Supply Chain (NASDAQ:CTNT) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreBIO-key Intl (NASDAQ:BKYI) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreAkari Therapeutics (NASDAQ:AKTX) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreREalloys (NASDAQ:ALOY) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreAktis Oncology (NASDAQ:AKTS) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreRenX Enterprises (NASDAQ:RENX) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read more